Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 03-2008 | 12-2007 | 09-2007 | 06-2007 | 03-2007 | |
| Sales | 725 | 403 | 578 | 623 | -4 |
| Cost of Goods | N/A | N/A | N/A | 348 | N/A |
| Gross Profit | 725 | 403 | 926 | 275 | -4 |
| Operating Expenses | 7,543 | 7,131 | 8,332 | 18,014 | 7,469 |
| Operating Income | -6,819 | -6,729 | -7,754 | -17,392 | -7,473 |
| Other Income | 248 | 329 | 385 | 238 | 328 |
| Pre-tax Income | -6,571 | -6,400 | -7,369 | -17,154 | -7,145 |
| Net Income Continuous | -5,426 | -5,064 | -6,947 | -12,272 | -6,174 |
| Net Income Discontinuous | -269 | -170 | -626 | -205 | N/A |
| Net Income | $-5,695 | $-5,234 | $-7,573 | $-12,478 | $-6,174 |
| EPS Basic Total Ops | -1.50 | -1.40 | -1.90 | -3.50 | -1.80 |
| EPS Basic Continuous Ops | -1.40 | -1.30 | -1.81 | -3.40 | -1.80 |
| EPS Basic Discontinuous Ops | -0.10 | -0.10 | -0.10 | -0.10 | N/A |
| EPS Diluted Total Ops | -1.50 | -1.40 | -1.90 | -3.50 | -1.80 |
| EPS Diluted Continuous Ops | -1.40 | -1.30 | -1.81 | -3.40 | -1.80 |
| EPS Diluted Discontinuous Ops | -0.10 | -0.10 | -0.10 | -0.10 | N/A |
| EBITDA(a) | $-6,521 | $-6,443 | $-7,468 | $-17,139 | $-7,238 |